Capital expenditure · 2011–2025
Novavax capital expenditure
$5.6M−57.4% · FY2025
Novavax (NVAX) reported $5.6M in capital expenditure for fiscal 2025, −57.4% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $5.6M | −57.4% | Open → |
| FY20242024-12-31 | $13.1M | −75.7% | Open → |
| FY20232023-12-31 | $53.8M | −39.6% | Open → |
| FY20222022-12-31 | $89.1M | +54.9% | Open → |
| FY20212021-12-31 | $57.5M | +5.2% | Open → |
| FY20202020-12-31 | $54.6M | +2,841.4% | Open → |
| FY20192019-12-31 | $1.9M | +35.3% | Open → |
| FY20182018-12-31 | $1.4M | −67.2% | Open → |
| FY20172017-12-31 | $4.2M | −77.0% | Open → |
| FY20162016-12-31 | $18.2M | −0.4% | Open → |
| FY20152015-12-31 | $18.3M | +151.3% | Open → |
| FY20142014-12-31 | $7.3M | +25.6% | Open → |
| FY20132013-12-31 | $5.8M | +33.3% | Open → |
| FY20122012-12-31 | $4.3M | +611.6% | Open → |
| FY20112011-12-31 | $610,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +17.1%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novavax capital expenditure |url=https://companiesranked.com/en/company/novavax/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novavax capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/novavax/capital-expenditureBibTeX
@misc{companiesranked-en-company-novavax-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Novavax capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novavax/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001000694-26-000007 · February 26, 2026
{{cite web |title=Novavax capital expenditure — 10-K (0001000694-26-000007) |url=https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.